Home › Hyperthyroidism › California
Pag-aaral pangklinika para sa Hyperthyroidism sa California
7 pag-aaral para sa Hyperthyroidism ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1111, Torrance
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07305818Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-032, Burbank
- Site-062, Huntington Beach
- Site-048, Oakland
- at 2 pa
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07661056A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- AME Clinical Research, Los Angeles
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07722546Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 121, La Mesa
- Site 103, Sacramento
- Site 111, San Francisco
- at 1 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1061, Huntington Beach
- Site Number - 1001, Los Angeles
- Site Number - 1047, Los Angeles
- at 4 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06727604Study of BHV-1300 in Graves' Disease
- Site-103, South Gate
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06980649Evaluating an AI Tool for Detecting Thyrotoxic States
- Umesh Masharani, San Francisco
Nagre-recruitObservasyonal na pag-aaral
Edad 22 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT07017907Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.